1.American Psychiatric Association. Diagnostic and Statistical Manual, 4th ed., Text Revision (DSM-IV-TR). Washington, DC: American Psychiatric Press, Inc.; 2000.
2.Rief, W, Buhlmann, U, Wilhelm, S, Borkenhagen, A, Brähler, E. The prevalence of body dysmorphic disorder: a population-based survey. Psychol Med. 2006; 36(6): 877–885.
3.Faravelli, C, Salvatori, S, Galassi, F, etal. Epidemiology of somatoform disorders: a community survey in Florence. Soc Psychiatry Psychiatr Epidemiol. 1997; 32(1): 24–29.
4.Ruffolo, JS, Phillips, KA, Menard, W, Fay, C, Weisberg, RB. Comorbidity of body dysmorphic disorder and eating disorders: severity of psychopathology and body image disturbance. Int J Eat Disord. 2006; 39(1): 11–19.
5.Phillips, K, Menard, W, Fay, C. Gender similarities and differences in 200 individuals with body dysmorphic disorder. Compr Psychiatry. 2006; 47(2): 77–87.
6.Koran, LM, Abujaoude, E, Large, MD, Serpe, RT. The prevalence of body dysmorphic disorder in the United States adult population. CNS Spectr. 2008; 13(4): 316–322.
7.Phillips, K, Dufresne, RG Jr. Body dysmorphic disorder: a guide for primary care physicians. Prim Care. 2002; 29(1): 99–111.
8.Phillips, KA. Quality of life for patients with body dysmorphic disorder. J. Nerv Ment Dis. 2000; 188(3): 170–175.
9.Phillips, KA, Menard, W, Fay, C, Pagano, ME. Psychosocial functioning and quality of life in body dysmorphic disorder. Compr Psychiatry. 2005; 46(4): 254–260.
10.Veale, D. Body dysmorphic disorder. Postgrad Med J. 2004; 80(940): 67–71.
11.Phillips, KA, Rasmussen, SA. Change in psychosocial functioning and quality of life of patients with body dysmorphic disorder treated with fluoxetine: a placebo-controlled study. Psychosomatics. 2004; 45(5): 438–444.
12.Phillips, KA. Suicidality in body dysmorphic disorder. Prima Psychiatry. 2007; 14(12): 58–66.
13.Didie, ER, Tortolani, C, Walters, M, etal. Social functioning in body dysmorphic disorder: assessment considerations. Psychiatr Q. 2007; 77(3): 223–229.
14.Hrabosky, JI, Cash, TF, Veale, D, etal. Multidimensional body image comparisons among patients with eating disorders, body dysmorphic disorder, and clinical controls: a multisite study. Body Image. 2009; 6(3): 155–163.
15.Marques, L, Leblanc, N, Robinaugh, D, etal. Correlates of quality of life and functional disability in individuals with body dysmorphic disorder. Psychosomatics. 2011; 52(3): 245–254.
16.Phillips, KA, Pagano, ME, Menard, W, Stout, RL. A 12-month follow-up study of the course of body dysmorphic disorder. Am J Psychiatry. 2006; 163(5): 907–912.
17.Crerand, C, Phillips, K, Menard, W, Fay, C. Nonpsychiatric medical treatment of body dysmorphic disorder. Psychosomatics. 2005; 46(6): 549–555.
18.Nachshoni, T, Kotler, M. Legal and medical aspects of body dysmorphic disorder. Med Law. 2007; 26(4): 721–735.
19.Coles, ME, Phillip, KA, Menard, W, etal. Body dysmorphic disorder and social phobia: cross-sectional and prospective data. Depress Anxiety. 2006; 23(1): 26–33.
20.Grant, JE, Menard, W, Pagano, ME, Fay, C, Phillips, KA. Substance use disorders in individuals with body dysmorphic disorder. J Clin Psychiatry. 2005; 66(3): 309–316.
21.Fals-Steward, W, Schafer, J. The treatment of substance abusers with obsessive-compulsive disorder: an outcome study. J Subst Abuse Treat. 1992; 9(4): 365–370.
22.Gunstad, J, Phillips, KA. Axis I comorbidity in body dysmorphic disorder. Compr Psychiatry. 2003; 44(4): 270–276.
23.Didie, ER, Walters, MM, Pinto, A, etal. A comparison of quality of life and psychosocial functioning in obsessive-compulsive disorder and body dysmorphic disorder. Ann Clin Psychiatry. 2007; 19(3): 181–186.
24.Phillips, KA, Stout, RL. Associations in the longitudinal course of body dysmorphic disorder with major depression, obsessive compulsive disorder, and social phobia. J Psychiatr Res. 2006; 40(4): 360–369.
25.Phillips, K, Hollander, E. Treating body dysmorphic disorder with medication: evidence, misconceptions, and a suggested approach. Body Image. 2008; 5(1): 13–27.
26.Williams, J, Hadjistavropoulos, T, Sharpe, D. A meta-analysis of psychological and pharmacological treatments for body dysmorphic disorder. Behav Res Ther. 2006; 44(1): 99–111.
27.Grant, JE, Phillips, KA. Recognizing and treating body dysmorphic disorder. Ann Clin Psychiatry. 2005; 17(4): 205–210.
28.Phillips, KA, Menard, W. A prospective pilot study of levetiracetam for body dysmorphic disorder. CNS Spectr. 2009; 14(5): 252–260.